FDA Issues Warning on Johnson & Johnson's HIV Drug
WASHINGTON - Health regulators have warned doctors about a possible link between a Johnson & Johnson HIV drug and potentially fatal liver damage. The Food and Drug Administration said Friday it has received reports of drug-induced hepatitis in patients taking J&J's Prezista, which is used in combination with another HIV drug ritonavir.